Takao Shinohara

  • Citations Per Year
Learn More
The combination of doxorubicin and cyclophosphamide is a standard chemotherapy regimen for breast cancer. Nausea and vomiting are two common adverse effects that may lead to a significant(More)
In order to see how the medical costs will change when the DPC (Diagnosis Procedure Combination) is implemented, the team calculated possible fees on DPC for patients who received weekly TC(More)
  • 1